Variant report
Variant | nsv526109 |
---|---|
Chromosome Location | chr5:116824450-116825352 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:116791221..116793114-chr5:116823128..116825426,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs890779 | chr5:116824450-116824451 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
2 | rs550461267 | chr5:116824451-116824452 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375924692 | chr5:116824467-116824468 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73258839 | chr5:116824481-116824482 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs377647652 | chr5:116824489-116824490 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs34993111 | chr5:116824493-116824494 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187096055 | chr5:116824512-116824513 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs546651196 | chr5:116824556-116824557 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566149309 | chr5:116824559-116824560 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs35336726 | chr5:116824560-116824561 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535057187 | chr5:116824569-116824570 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs13357216 | chr5:116824644-116824645 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs137995863 | chr5:116824656-116824657 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569169460 | chr5:116824662-116824663 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs191602148 | chr5:116824687-116824688 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs560397519 | chr5:116824761-116824762 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs558116026 | chr5:116824823-116824824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs578107492 | chr5:116824838-116824839 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs370880394 | chr5:116824862-116824863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs540406345 | chr5:116824871-116824872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554273194 | chr5:116824872-116824873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs184464508 | chr5:116824935-116824936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs187348190 | chr5:116825018-116825019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs561970191 | chr5:116825028-116825029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530752130 | chr5:116825049-116825050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs555691713 | chr5:116825062-116825063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149479139 | chr5:116825075-116825076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs12521666 | chr5:116825105-116825106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs143048319 | chr5:116825185-116825186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs57106106 | chr5:116825222-116825223 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs1863977 | chr5:116825352-116825353 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:116823200-116824800 | Weak transcription | NHDF-Ad | bronchial |
2 | chr5:116824200-116825200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr5:116824200-116826200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
4 | chr5:116824400-116824600 | Enhancers | Rectal Mucosa Donor 31 | rectum |
5 | chr5:116824400-116825200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
6 | chr5:116824800-116825200 | Enhancers | NHDF-Ad | bronchial |
7 | chr5:116825200-116825800 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
8 | chr5:116825200-116829000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr5:116825200-116829400 | Weak transcription | NHDF-Ad | bronchial |